Toukeibu Gan
Online ISSN : 1881-8382
Print ISSN : 1349-5747
ISSN-L : 1349-5747
The current status of the treatment for T4 maxillary sinus cancer in Japan – a multi-institutional retrospective observation study
Akihiro HommaRyuichi HayashiKazuto MatsuuraKengo KatoKazuyoshi KawabataNobuya MondenYasuhisa HasegawaTetsuro OnitsukaYasushi FujimotoShigemichi IwaeKenji OkamiTakashi MatsuzukaKunitoshi YoshinoMasato Fujii
Author information
JOURNAL FREE ACCESS

2013 Volume 39 Issue 3 Pages 310-316

Details
Abstract
[Purpose] To assess the current status in Japan of the treatment for squamous cell carcinoma of the T4 maxillary sinus (MS-SCC) and its use to plan clinical trials in the future.
[Patients] The data for 128 patients with previously untreated MS-SCC were obtained from 28 institutions from 2006 to 2007. Of the 128 patients, 118 patients with curative intent were included in an analysis of the treatment and its results.
[Results] Of the 118 patients, 73 patients had T4a disease, and 45 with T4b. Thirty-nine patients (33.1%) were treated with total maxillectomy, 25 (21.2%) with partial maxillectomy, 22 patients (18.6%) with RADPLAT, 19 patients (16.1%) with IV-CRT, and 13 patients (11.0%) with others. The 5-year overall survival rate and local control rate for 118 patients were 49.8% and 48.9%, respectively. The 5-year overall survival rates for patients with T4aN0M0 and T4bN0M0 were 67.5% and 29.8%, respectively.
[Conclusion] This study was retrospective, but we could understand the tendency of treatment choice and treatment results. It will be useful information to plan clinical trials in the future.
Content from these authors
© 2013 Japan Society for Head and Neck Cancer
Previous article Next article
feedback
Top